These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 28796777)
1. Surface active properties of lipid nanocapsules. Mouzouvi CRA; Umerska A; Bigot AK; Saulnier P PLoS One; 2017; 12(8):e0179211. PubMed ID: 28796777 [TBL] [Abstract][Full Text] [Related]
2. Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants. Umerska A; Cassisa V; Matougui N; Joly-Guillou ML; Eveillard M; Saulnier P Eur J Pharm Biopharm; 2016 Nov; 108():100-110. PubMed ID: 27597268 [TBL] [Abstract][Full Text] [Related]
3. Preparation and Optimization Lipid Nanocapsules to Enhance the Antitumor Efficacy of Cisplatin in Hepatocellular Carcinoma HepG2 Cells. Zhai Q; Li H; Song Y; Wu R; Tang C; Ma X; Liu Z; Peng J; Zhang J; Tang Z AAPS PharmSciTech; 2018 Jul; 19(5):2048-2057. PubMed ID: 29679292 [TBL] [Abstract][Full Text] [Related]
4. Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133. Bourseau-Guilmain E; Béjaud J; Griveau A; Lautram N; Hindré F; Weyland M; Benoit JP; Garcion E Int J Pharm; 2012 Feb; 423(1):93-101. PubMed ID: 21683129 [TBL] [Abstract][Full Text] [Related]
5. Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms. Perrier T; Saulnier P; Fouchet F; Lautram N; Benoît JP Int J Pharm; 2010 Aug; 396(1-2):204-9. PubMed ID: 20600733 [TBL] [Abstract][Full Text] [Related]
6. Understanding the Thermodynamic Mechanisms Leading to the Binding of Albumin to Lipid Nanocapsules. Umerska A; Sapin-Minet A; Parent M; Tajber L; Maincent P; Boudier A Langmuir; 2020 Apr; 36(15):4165-4173. PubMed ID: 32223171 [TBL] [Abstract][Full Text] [Related]
7. Formulation and nebulization of fluticasone propionate-loaded lipid nanocarriers. Umerska A; Mouzouvi CR; Bigot A; Saulnier P Int J Pharm; 2015 Sep; 493(1-2):224-32. PubMed ID: 26183331 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity and genotoxicity of lipid nanocapsules. Le Roux G; Moche H; Nieto A; Benoit JP; Nesslany F; Lagarce F Toxicol In Vitro; 2017 Jun; 41():189-199. PubMed ID: 28323104 [TBL] [Abstract][Full Text] [Related]
9. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability. Paillard A; Hindré F; Vignes-Colombeix C; Benoit JP; Garcion E Biomaterials; 2010 Oct; 31(29):7542-54. PubMed ID: 20630585 [TBL] [Abstract][Full Text] [Related]
10. Enhanced optical imaging properties of lipid nanocapsules as vehicles for fluorescent conjugated polymers. Modicano P; Neumann PR; Schüller M; Holthof J; Kyrilis FL; Hamdi F; Kastritis PL; Mäder K; Ann Dailey L Eur J Pharm Biopharm; 2020 Sep; 154():297-308. PubMed ID: 32707286 [TBL] [Abstract][Full Text] [Related]
11. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy. Zhang L; Tian B; Li Y; Lei T; Meng J; Yang L; Zhang Y; Chen F; Zhang H; Xu H; Zhang Y; Tang X ACS Appl Mater Interfaces; 2015 Nov; 7(45):25147-61. PubMed ID: 26501354 [TBL] [Abstract][Full Text] [Related]
12. Inner ear biocompatibility of lipid nanocapsules after round window membrane application. Zhang Y; Zhang W; Löbler M; Schmitz KP; Saulnier P; Perrier T; Pyykkö I; Zou J Int J Pharm; 2011 Feb; 404(1-2):211-9. PubMed ID: 21075187 [TBL] [Abstract][Full Text] [Related]
13. Conventional versus stealth lipid nanoparticles: formulation and in vivo fate prediction through FRET monitoring. Lainé AL; Gravier J; Henry M; Sancey L; Béjaud J; Pancani E; Wiber M; Texier I; Coll JL; Benoit JP; Passirani C J Control Release; 2014 Aug; 188():1-8. PubMed ID: 24878182 [TBL] [Abstract][Full Text] [Related]
14. Lipid nanocapsules for transdermal delivery of ropivacaine: in vitro and in vivo evaluation. Zhai Y; Yang X; Zhao L; Wang Z; Zhai G Int J Pharm; 2014 Aug; 471(1-2):103-11. PubMed ID: 24858383 [TBL] [Abstract][Full Text] [Related]
15. Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma. Huynh NT; Passirani C; Allard-Vannier E; Lemaire L; Roux J; Garcion E; Vessieres A; Benoit JP Int J Pharm; 2012 Feb; 423(1):55-62. PubMed ID: 21536115 [TBL] [Abstract][Full Text] [Related]
16. Surface modification of lipid nanocapsules with polysaccharides: from physicochemical characteristics to in vivo aspects. Hirsjärvi S; Dufort S; Bastiat G; Saulnier P; Passirani C; Coll JL; Benoît JP Acta Biomater; 2013 May; 9(5):6686-93. PubMed ID: 23395817 [TBL] [Abstract][Full Text] [Related]
17. In vivo imaging of DNA lipid nanocapsules after systemic administration in a melanoma mouse model. David S; Carmoy N; Resnier P; Denis C; Misery L; Pitard B; Benoit JP; Passirani C; Montier T Int J Pharm; 2012 Feb; 423(1):108-15. PubMed ID: 21726617 [TBL] [Abstract][Full Text] [Related]
18. Improvement of the oral bioavailability of coenzyme Q10 with lecithin nanocapsules. Zhou H; Zhang J; Long Y; Liu G; Duan M; Xia Q J Nanosci Nanotechnol; 2013 Jan; 13(1):706-10. PubMed ID: 23646802 [TBL] [Abstract][Full Text] [Related]
19. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery. Kumar BS; Saraswathi R; Kumar KV; Jha SK; Venkates DP; Dhanaraj SA Drug Deliv; 2014 May; 21(3):173-84. PubMed ID: 24102185 [TBL] [Abstract][Full Text] [Related]